Cite

    Furlan, C. et al. (2015). Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis. Biomarker research. 3 (1), pp. 1-3. [Online].